Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Morphosys (GB:0NDV – Research Report), Thales (GB:0IW5 – Research Report) and Capgemini SE (GB:0HAZ – Research Report).
Morphosys (GB:0NDV)
In a report released yesterday, Xian Deng from UBS maintained a Hold rating on Morphosys, with a price target of EUR68.00. The company’s shares closed yesterday at EUR66.20, close to its 52-week low of EUR65.10.
Deng has an average return of
According to TipRanks.com, Deng is ranked #700 out of 8800 analysts.
The word on The Street in general, suggests a Hold analyst consensus rating for Morphosys with an EUR60.60 average price target, a -7.6% downside from current levels. In a report released yesterday, Oddo BHF also downgraded the stock to Hold with a EUR68.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Thales (GB:0IW5)
In a report released yesterday, Chloe Lemaire from Jefferies maintained a Buy rating on Thales, with a price target of EUR180.00. The company’s shares closed yesterday at EUR157.97.
According to TipRanks.com, Lemaire is a 5-star analyst with an average return of
Currently, the analyst consensus on Thales is a Moderate Buy with an average price target of EUR164.82, a 3.2% upside from current levels. In a report issued on April 15, Berenberg Bank also maintained a Buy rating on the stock with a EUR180.00 price target.
Capgemini SE (GB:0HAZ)
In a report released yesterday, Chandramouli Sriraman from Stifel Nicolaus maintained a Buy rating on Capgemini SE, with a price target of EUR245.00. The company’s shares closed yesterday at EUR210.70.
Sriraman has an average return of
According to TipRanks.com, Sriraman is ranked #2360 out of 8800 analysts.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Capgemini SE with an EUR241.43 average price target, which is a 15.2% upside from current levels. In a report issued on April 24, Jefferies also maintained a Buy rating on the stock with a EUR255.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on GB:0NDV:
- MorphoSys downgraded to Neutral from Outperform at Oddo BHF
- Morphosys AG (0NDV) Q1 Earnings Cheat Sheet
- MorphoSys board recommends shareholders accept Novartis offer
- MorphoSys Management, Supervisory board recommend Novartis takeover
- Post-Takeover Turbulence: MorphoSys AG Faces Liquidity Crisis and Index Exclusion Risks
